IHS Chemical Week

People & Business :: People/Executives

Ashland CEO to Have Surgery, Return to Full Duty in 2-3 Months

6:48 AM MDT | March 17, 2011 | Robert Westervelt

Ashland says that its chairman and CEO James J. O'Brien will undergo surgery to repair a perforated colon resulting from diverticulitis, and is expected to return to full duties in two to three months. O'Brien will be available on a limited basis during the recovery period. Ashland's chairman duties will be assumed Barry Perry, lead independent director and former chairman and CEO of Engelhard, during O'Brien's recovery. O’Brien’s executive duties will be assumed jointly by Lamar Chambers, Ashland's senior v.p. and CFO, and David L. Hausrath...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa